Developing CES Reaction Phenotyping Assay:
Insights from our APA 2025 Poster Presentation.
Reaction phenotyping is a cornerstone of drug metabolism studies, routinely applied to cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes, to identify the main enzymes responsible for the metabolism of a new drug. Carboxylesterases (CES), particularly CES1b, CES1c, and CES2, play a critical role in the biotransformation of ester- and amide-containing compounds. Their involvement is essential for the metabolic fate of such drug molecules, especially when CYP-mediated metabolism is minimal or absent.
Our work, presented at APA 2025, focuses on developing an in vitro CES reaction phenotyping using p-nitrophenyl acetate (p-NPA) as a universal substrate. In this study, we compared different CES substrates, optimized the experimental conditions and developed an LC-MS method for simultaneous detection of p-NPA and its metabolites.
Key Highlights:
- The incubation concentrations of CES substrate (p-NPA )and the protein concentrations of various supersomes were optimized.
- p-NPA showed measurable depletion and metabolite formation in CES1b, CES1c, and CES2 supersomes.
- Half-lives of p-NPA in CES isoforms were significantly shorter than in buffer controls, confirming enzymatic activity.
We employed p-NPA as a universal substrate to optimize and establish a CES reaction phenotyping assay, which supports the metabolic evaluation and drug-drug interaction assessment of ester-containing compounds in early-stage drug development. These findings support the inclusion of CES phenotyping in early drug development, particularly for ester-containing compounds, and aid in improving in vitro–in vivo extrapolation (IVIVE) models.
Download the poster below and contact us if you would like to discuss in more detail.
Ready to resolce your DMPK challenges?
CPartner with the global bioanalytical sciences provider that delivers scientific excellence, regulatory expertise, and seamless project management.
